Cancer prognosis was mainly done by imaging and biopsy with histological analysis of solid tumours.
modalities have their strengths and limitations. Hence multimodality imaging that takes advantage of strengths from two or more imaging techniques may serve improved diagnostic and therapeutic monitoring abilities. Radiolabelled small molecules have been used as contrast agents to detect tumour for prognosticating therapeutic interventions. However, these probes lack tissue specificity and stability for optimal usage. Fluorescent small molecules and radiolabeled albumins (e.g., technetium-99m) [12] , are commonly used agents identify lymph nodes as they are highly sensitive, however, it lacks specificity for tumour and low signalto-noise ratio and associated with harmful radiation effects. Fluorescence imaging is highly sensitive and its resolution is in the order of micro-meter at the tissue surface. However, fluorescence imaging in the clinical settings are limited in use due to requirement of more depth of penetration, good signal intensity, and stability [13] . Therefore, designing the probe that overcomes all these limitations is essential for extensive clinical application specifically during surgical procedure. 
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QDs can be conjugated with peptides, proteins, Choi D et al [90] Antibody attached micro bubbles [115, 116] Peptide attached micro bubbles [117, 118] Optical Imaging 
Summary
Molecular imaging using QDs is found to be effective for cancer imaging both in-vitro and in-vivo conditions. 
Conclusion
The 
